NASDAQ
Standard BioTools Inc. (LAB) has a free cash flow growth of -2719.31% as of Friday, May 29, 2026. This represents a 45509.53% decrease compared to its 12-month average of 5.99%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.